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The incidence of diabetes is increasing globally. 
Africa is no exception: the number of adults with 
diabetes is expected to almost double by 2030 to 23.9 
million.[1] Diabetes is clearly becoming a pressing 
public health problem for Africa, for which effective 
interventions are required in the near future to avert the anticipated 
health burden. One such intervention is the introduction of a diabetic 
retinal screening programme for the early detection of diabetic 
retinopathy (DR) and the prevention of blindness.
Studies estimating the impact of screening programmes in Europe 
have concluded that they achieved worthwhile health gains and 
substantial reductions in the incidence of new blindness due to 
DR.[2,3] The introduction of a European-style screening programme 
in the African context is unlikely in the near future. However, 
raising current screening expertise and fully exploiting the available 
technology has the potential for significant health gains.
DR screening in South Africa (SA) is done on an ad hoc and 
opportunistic basis by a spectrum of healthcare providers. These provi-
ders have invested in fundus camera technology capable of producing 
high-resolution retinal images. This technology is key to established 
screening programmes, and is core technology for national screening 
approaches elsewhere. The ability to acquire and record high-quality 
retinal images is, however, only the first step: effective interpretation 
is essential to any screening process. How that screening expertise is 
disseminated and maintained is a challenge for national and professional 
bodies that wish to address the increasing health burden.
The Ophthalmological Society of South Africa (OSSA) has deve-
loped a framework for a national Diabetic Retinopathy Screening 
Programme that can accommodate the many sectors in the healthcare 
environment. This includes traditional teaching methods such as 
lecturing and publication. A key part of this framework is a quality 
assurance process that will encourage ongoing learning and the 
monitoring of performance.
The Scottish External Quality Assurance (EQA) process is an 
internet-based assessment tool for the Scottish Diabetic Retinopathy 
Screening collaborative. The programme has been in place since 
2007. It includes a compulsory twice-yearly procedure that involves 
all screeners working for the National Health Service in Scotland. 
Once completed and assessed, feature-based feedback is given to 
individual screeners and the lead person responsible at each screening 
site. The process involves each screener grading 100 retinal images. 
These grades are compared with a reference standard generated 
from the consensus of the expert graders, who are experienced 
ophthalmologists with a high level of proficiency in assessing retinal 
images. Longitudinal analysis of screener performance has shown 
that it significantly improves performance for all grades of screener.[4] 
It has enabled the service to assess individual screeners and sites, to 
identify strengths and weaknesses, and to improve quality.
Using this software, the current study assessed the performance 
of volunteer screeners in SA, by comparison with a group of 
expert graders from the Scottish service. We aimed to assess the 
feasibility of the EQA process in SA; to compare the performance of 
Quality assurance in diabetic retinal screening 
in South Africa
S Cook,1 MB BCh, FCS (Ophth) (SA); R T Staff,2,3 PhD; K A Goatman,4 PhD; J A Olson,4,5 MD, FRCPE, FRCOphth;  
and the Scottish Diabetic Retinopathy Screening collaborative
1  The Eye Centre, East London, Eastern Cape, South Africa, and Department of Ophthalmology, Faculty of Health Sciences,  
Walter Sisulu University, Umtata, Eastern Cape, South Africa
2  Aberdeen Biomedical Imaging Centre, University of Aberdeen, Aberdeen, Scotland, UK
3 Aberdeen Royal Infirmary, NHS Grampian, Scotland, UK
4  School of Medicine and Dentistry, University of Aberdeen, Scotland, UK
5  Retinal Screening, Aberdeen Royal Infirmary, NHS Grampian, Scotland, UK
Corresponding author: S Cook (dr@eyecentre.co.za)
Background. Diabetic retinopathy (DR) is an important biomarker for microvascular disease and blindness. Digital fundus photography is 
a cost-effective way of screening for DR. Access to DR screening is difficult for many South Africans with diabetes.
Objective. To perform external quality assurance (EQA) on graders registered in the Ophthalmological Society of South Africa DR 
screening programme.
Methods. Graders registered on the South African (SA) Diabetic Register website were invited to participate in the study. The Scottish 
EQA software system was used to enable on-line grading of 100 retinal photographs. Expert National Health Service graders provided the 
consensus expert grading for the image set.
Results. Two hundred and sixty-one participants completed the EQA process, including nine ophthalmologists, 243 optometrists, and nine 
other graders. A wide range of outcomes were demonstrated, with a mean sensitivity of 0.905 (range 0.286 - 1.000) and mean specificity of 
0.507 (0.000 - 0.935). The mean diagnostic odds ratio was calculated to be 12.3 (range 0.147 - 148.2).
Conclusions. This is the first quality assurance study conducted with SA healthcare professionals. The outcomes are of interest to all 
stakeholders dealing with the diabetes epidemic. The disparity in grader performance indicates room for improvement. The results 
demonstrate a high referral rate to ophthalmology, suggesting that on average graders are performing safely, but with a high number of 
inappropriate referrals.
S Afr Med J 2014;104(10):700-704. DOI:10.7196/SAMJ.8678
RESEARCH
701       October 2014, Vol. 104, No. 10
screening groups; and to identify potential 
improvements in the screening practice of 
individuals with a view to future personal 
and group feedback and training.
Methods
Screener recruitment
The Diabetic Retinopathy Screening 
Programme was advertised and promoted 
by a variety of means: conference 
presentations, personal contact, posters, and 
publications in the SAMJ and the Diabetic 
Register website (www.diabeticregister.
co.za). The Diabetic Register is a closed 
user group site for healthcare professionals. 
Individuals who expressed an interest were 
invited to participate in the EQA process. 
The minimum requirements to take part 
in the study were access to the internet, an 
e-mail account, and an occupation with 
the requirement or opportunity for retinal 
screening. Those who indicated interest 
were sent a link to a web-based survey to 
establish their professional characteristics, 
e.g. post type, experience and workload 
(www.surveymonkey.com/s/B6B3BNC). 
Once the survey had been completed, a 
further link was sent explaining how to 
access the EQA site and carry out the 
EQA process. The site was open for data 
collection between November 2013 and 
January 2014. Technical support in grading 
was provided by a dedicated employee of 
the Eye Centre in East London, Eastern 
Cape, SA. Queries that could not be 
resolved locally were dealt with by the EQA 
experts in Scotland.
Running in parallel to this process, expert 
graders from the Scottish diabetic retinal 
screening service were asked to participate 
so as to provide an external consensus 
reference standard. These graders have all 
been part of the screening service for more 
than 5 years, have been tested regularly via 
the EQA process, have significant screening 
workloads, and have been shown to be high 
and consistent performers.
Image selection
The retinal images used in this study were selec-
ted by one of the authors (SC). Anonymised 
images were selected from the Eye Centre 
fundus photo database. There was no pre-
selection for quality or level of retinopathy.
The EQA process
The EQA web-based software closely 
matches the feature-based grading system 
used in Scotland. The interface (Fig. 1) is 
compatible with all popular web browsers 
and consists of an image display on the 
left, together with controls for contrast, 
brightness, zoom and red-free colour 
display, a ruler for measuring the size of 
features, and a feature grading panel on 
the right-hand side. The number of times 
these controls were used was recorded for 
each screener, along with the time taken 
for grading all the images. Each grader was 
presented with the images in a different 
random order. Screeners were also allowed 
to use a ‘sandbox’ feature that enabled them 
Table 1. A summary of the Scottish Diabetic Retinopathy Grading Scheme 
Grading Description Outcome
R0 (no visible retinopathy) No visible diabetic retinopathy anywhere Re-screen in 12 months
R1 (mild) At least one dot, blot or flame haemorrhage, microaneurysm, exudate or 
cotton-wool spot anywhere
Re-screen in 12 months
R2 (observable background) Four or more blot haemorrhages (>AH standard photograph 2a) in one 
hemi-field only (where the inferior and superior hemi-fields are delineated 
by a line passing through the centres of the fovea and optic disc)
Re-screen in 6 months
R3 (referable background) Any of the following features: (i) four or more blot haemorrhages 
(>AH standard photograph 2a) in the inferior and superior hemi-fields; 
(ii) venous beading (>AH standard photograph 6a); (iii) intraretinal 
microvascular anomalies (>AH standard photograph 8a)
Refer to ophthalmology
R4 (proliferative) Any of the following features: (i) active new vessels; (ii) vitreous 
haemorrhage
Refer to ophthalmology
R6 (inadequate) Insufficient clarity or field of view Slit-lamp examination
M1 (observable maculopathy) Exudate within a radius of >1 but <2 disc diameters of the centre of the 
fovea
Re-screen in 6 months
M2 (referable maculopathy) Any blot haemorrhage or exudate within a radius of 1 disc diameter of 
the centre of the fovea
Refer to ophthalmology
AH = Airlie House standard photography scheme.[9]
Fig. 1. The External Quality Assurance software interface.
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to become familiar with the system by 
grading example images prior to grading 
the test images.
The software implements the Scottish 
grading scheme (http://www.ndrs-wp.
scot.nhs.uk), summarised in Table 1. The 
retinopathy grades are derived automatically 
from the features the grader selects. There 
are eight possible grading outcomes: four 
of these outcomes require referral (M2, R3, 
R4 and R6), and two indicate more frequent 
review with a 6-month interval (M1 and R2). 
The remaining two categories (R0 and R1) 
result in re-screening in 12 months.
Results
The promotion process generated interest 
from 398 individuals. These individuals 
accessed the survey site, filled in the 
questionnaire and gave permission for their 
data to be used. Two hundred and sixty-
one participants gave all the information 
requested, and went on to register on the 
EQA site and complete the process. The 
characteristics of this group are shown in 
Table 2.
The nine expert graders achieved a 
consensus on the grading of 90 out of the 
100 images. The responses to these images 
by each participant were used to assess the 
participant’s performance. According to the 
expert external screeners, the 90 images were 
classified as follows: R0 – 22, R1 – 38, M1 – 
2, R2 – 0, R6 – 2, M2 – 13, R3 – 4, R4 – 9.
Fig. 2 shows the sensitivity and specificity 
of each participant in a receiver operating 
characteristic (ROC) diagram. Each circle 
represents a single participant. The squares 
represent the performance of the external 
expert graders. All graders were assessed 
using the consensus grades as the reference 
standard. The top left-hand corner indicates 
the best screener performance. The expert 
graders are shown as dark blue squares. The 
SA graders are represented as lighter blue 
circles. Note that the expert graders would 
be expected to perform better, as they each 
contributed to the standard.
There is a significant variation in the per-
formance across all graders. For example, 
at one extreme, a grader detects just over 
20% of cases, which would normally be 
referred to an eye clinic for ophthalmology 
assessment; while at the other, two graders 
have 0% specificity – i.e. they are sending 
everyone to the eye clinic. Table 3 shows 
the agreement (or lack thereof) between 
the participants and the external expert 
screeners. This table shows how images of 
each grade were graded: the grades along 
the top show the most serious retinopathy 
or maculopathy grade according to the 
standard. The leading diagonal (in bold 
italics) indicates exact agreement between 
the standard and the graders. Note that none 
of the images had a consensus grading of R2 
(observable retinopathy) or R6 (technical 
failure, unassessable image). The bottom 
left-hand corner (in bold) indicates ‘over-
grading’ according to the standard, and the 
top right-hand corner (in italics) indicates 
‘under-grading’ of referable images. The 
numbers at the end of the rows and columns 
show the total number of grades in that row 
or column.
In general, these findings indicate a lack of 
specificity in those screeners who took part. 
The participating group was heterogeneous, 
with a range of experience, occupations 
and workloads. The following estimates 
Table 2. Participant sample and performance by characteristic
n AUC (SE) DOR (95% CI)
Post
Other 9 0.922 (0.025) 25.81 (14.41 - 46.24)*
Ophthalmologist 9 0.842 (0.009) 22.48 (13.53 - 37.36)*
Optometrist 243 0.842 (0.009) 11.57 (10.14 - 13.21)
Experience (year/s)
<1 110 0.825 (0.012) 11.12 (9.35 - 13.21)
2 - 5 60 0.833 (0.026) 11.64 (8.25 - 16.42)
>6 91 0.842 (0.009) 13.68 (11.25 - 16.63)
Competence
Novice 115 0.815 (0.011) 10.02 (8.52 - 11.61)*
Competent 122 0.815 (0.011) 12.55 (10.14 - 15.53)*
Experienced 24 0.897 (0.021) 24.11 (16.78 - 34.64)
Workload (examinations/month)
≤10 146 0.838 (0.011) 12.47 (10.69 - 14.53)
11 - 50 60 0.843 (0.019) 11.72 (8.62 - 15.93)
≥51 55 0.843 (0.019) 11.77 (8.73 - 15.87)
AUC = area under the receiver operating characteristic curve; SE = standard error; DOR = diagnostic odds ratio; 
CI = confidence interval.
*Mean statistically significantly different (p<0.05) from the group at the bottom of each section.
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Fig. 2. A scatter plot and ROC curve of grader performance in terms of sensitivity and specifi city. Each 
mark represents a single grader. Dark blue squares represent the external expert graders. Lighter blue 
circles represent the study participants. Th e ROC line was calculated from the study participants only. 
(ROC = receiver operating characteristic.)
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of the performance for each group were 
calculated: the area under the ROC curve 
(AUC) and diagnostic odds ratio (DOR) 
(Table 2). A comparison of the performance 
using the Metadisc software[5] found that the 
optometrist performance was inferior to the 
other two groups. Those who considered 
themselves experienced screeners performed 
better than the competent and the novice 
screeners. No difference was found to be 
associated with either the number of years of 
screening or workload.
In order to examine differences in screener 
behaviour, we ranked the participants in 
terms of performance (DOR) and divided 
them into three groups: low performers 
(DOR≤10.12, n=87), medium performers 
(10.12<DOR≤22.24, n=87) and high per-
formers (22.24>DOR, n=87). Table 4 shows 
the time taken and the mean use of the red 
filter, the zoom and the ruler by each of 
these performance groups. The use of these 
tools by the external expert reference group 
is also included for comparison. Differences 
between the groups were tested using a one-
way analysis of variance and a post hoc Tukey 
approach. It is clear from this table that the 
expert reference group took less time and 
used the tools more. In addition, within the 
tested groups, the more the tools were used 
the better the performance.
Discussion
DR has been identified as a valuable 
biomarker for systemic risk of microvascular 
complications of diabetes mellitus. With 
the publication of the Atherosclerosis Risk 
Study findings by Wong et al.[6] and the 
subsequent publication of the findings 
of the Japanese Diabetes Complications 
Study,[7] there has been a new appreciation 
of the importance of detecting any 
retinopathy. These studies demonstrated 
a significantly (approximately two times) 
increased risk of coronary heart disease 
and stroke in the study groups. This has 
changed the emphasis of screening for 
DR from a blindness prevention initiative 
(detection of advanced retinopathy) to a 
primary healthcare initiative (detection 
of any retinopathy). The importance of 
a biomarker for systemic complications 
at primary healthcare level cannot be 
overstated, particularly in a resource-poor 
setting. DR provides such characteristics.
There has been a general decline in the 
provision of screening by GPs in SA. This 
is because GPs only have ready access to 
direct ophthalmoscopy, a technology that 
has low sensitivity,[8] even in the best hands, 
and is unpopular with patients because it 
requires the pupils to be dilated. In the 
ophthalmic world, fundus photography has 
transformed the ability to detect disease as 
well as creating a permanent digital record. 
Fundus photography rather than direct 
ophthalmoscopy will therefore probably 
become the standard of care for DR. Patient-
friendly, good-quality fundus photography 
relies on image acquisition utilising non-
mydriatic cameras. These are capital-
intensive items that have not been available 
on a widespread basis in SA.
The OSSA DR programme has strived 
to lower the barriers to access to screening 
opportunities for people living with 
diabetes. OSSA has endorsed the use of non-
ophthalmologist graders to try to cope with 
the burden of disease. There is a widespread 
appreciation of the value of non-medical 
personnel as graders. These graders need 
the backing of a robust, scientific-quality 
assurance system. This initiative, coupled 
with optometrist interest, has seen the 
introduction of many new cameras into the 
SA healthcare market. A key public health 
issue has been to establish a responsible 
way of implementing quality assurance, 
encouraging participation and ongoing 
learning. Fundus photo screening is a new 
discipline in SA. This means that there is 
a wide range of levels of competence. A 
system of accreditation was required. This 
needed to be on an ongoing basis rather than 
a once-off pass/fail scenario. The system 
should encourage improvement over time. 
The Scottish EQA system has demonstrated 
these characteristics in the Scottish Diabetic 
Retinopathy Screening collaborative.
Table 3. Cross-agreement (%) between the external graders (standard) and the participants* 
Standard
Participants R0 R1 M1 R2 R6 M2 R3 R4 Total
R0 41.1 15.2 1.5   9.4 1.7 0.0 1.1 4 011
R1 30.1 36.5 18.6 19.5 8.6 1.1 5.4 5 979
M1 1.7 1.6 33.3 3.4 4.0 1.0 1.3 625
R2 0.3 1.1 1.7   0.6 1.1 1.1 0.4 194
R6 1.6 0.5 0.4   35.4 0.3 0.1 0.6 356
M2 10.6 21.4 5.7   9.4 43.1 8.2 8.3 4 554
R3 7.4 15.7 25.1   11.9 31.7 56.8 21.8 4 361
R4 7.3 7.9 13.6   10.3 9.3 31.8 61.0 3 410
Total 5 742 9 918 522 0 522 3 393 1 044 2 349
* The values are the percentage of images that were graded by the participants for each standard grading category. The values at the bottom of each column and at the end of each row represent the 
total number of images graded into each category by the external graders and participants, respectively.
The leading diagonal (bold italics) indicates exact agreement between the standard and the graders, the bottom left-hand corner (bold) indicates ‘over-grading’ according to the standard, and the 
top right-hand corner (italics) indicates ‘under-grading’ of referable images.
The grading outcomes are defined in Table 1.
Table 4. Screener use of the image manipulation tools and time taken
Group
Time taken (hours)
mean (SD)
Red filter (%)
mean (SD)
Zoom (%)
mean (SD)
Ruler (%)
mean (SD)
Low 3.91 (0.24) 57.62 (4.11)* 10.71 (1.98)* 9.39 (1.82)
Medium 4.17 (0.22)* 63.61 (3.58)* 25.30 (3.46)* 11.44 (1.53)
High 4.70 (0.27)* 69.38 (3.16)* 36.21 (3.67) 14.46 (1.74)
Expert 2.02 (0.23) 98.12 (1.18) 57.23 (13.20) 22.44 (5.12)
*Groups in which there is a significant difference between the participant group and the expert group (p<0.05).
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The Scottish Retinopathy Grading System was chosen for imple-
mentation in SA because of its simple, hierarchical grading of 
retinopathy characteristics. Simplicity and clear cut-offs for referrals 
are vital for management of DR. The inclusion of R2 with more 
frequent review at screening (primary) level is important for the 
public sector eye clinics, which are already swamped with blindness 
prevention work. The Scottish system and algorithm for referral 
has been moderated for the SA scenario to increase safety. The 
modifications are that any maculopathy (M1 or M2) is to be referred 
to ophthalmology, and the concept of systemic risk has been 
incorporated into the algorithm. This is particularly important in 
SA, where levels of control of diabetes and hypertension are generally 
very poor. The risk calculator developed by Prof. Einar Steffanson 
(www.risk.is) has been introduced for use in Africa (www.riskafrica.
co.za). This enables non-medical graders to calculate risk and modify 
the review period for poor control.
The outcomes were significantly better for the ophthalmologist 
group than for the optometrist group. More experienced graders had 
higher scores than those with less time since qualifying and a lower 
level of perceived experience. No significant difference was noted 
in outcome between the different daily workload groups. The wide 
range of performance across the groups was larger than that observed 
in the first Scottish EQA in 2008.[4] It is expected that this will be 
reduced and overall performance be improved over repeated EQAs, 
as happened in Scotland.
Safety of non-ophthalmologist graders was a concern. The 
results show that this group tended to over-refer rather than under-
refer. This was reassuring from a safety point of view, but it does 
mean that more cases than necessary would have been referred. 
Specificity will be the key aspect of training initiatives in order to 
address this. Furthermore, 12.6% of cases that should have been 
referred were not (compared with 4.6% calculated from the Scottish 
2010 EQA round).
The time taken to complete the task was similar between the 
different performance groups. Use of the tools increased with 
performance, with the high-performance group making the most 
use of the red-free filter, zoom and ruler controls. After the EQA 
process was completed, individual feedback and results were given 
anonymously to each participant. The individual was able to see 
his or her outcome relative to the peer group. Our plan is to repeat 
this process on an annual basis, encouraging new participants and 
monitoring performance. This system is thought to be ideal for the 
SA environment, where many graders possess their own cameras and 
would respond better to a peer group-driven incentive to improve 
rather than an absolute pass/fail outcome.
Study limitations
This study has a number of weaknesses that should be addressed 
in future work. Not all grading groups were present in our test set. 
When selected, the imaging mix was thought to contain examples 
of all possible outcomes. However, consensus was not reached by 
the expert graders, so grade R2 was not represented in the study 
set. It is difficult to assess experience and training as a predictor of 
performance. One would expect the more experienced and better 
trained to have superior performance, as we have crudely shown in 
Table 2. However, a better, more refined assessment of these factors 
will inform where educational efforts could best be focused. In 
general, our sample is a self-selected group who have expressed an 
interest; how these findings can be applied to the broader population 
performing such screening processes is unclear, although we have no 
reason to expect that our sample is not representative.
Conclusion
The process was well supported by participants and was able to 
demonstrate safety and areas of weakness that require training. The 
next SA EQA is scheduled to run in November 2014.
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